Hong Kong stock anomaly|Baoji Pharmaceutical-B (02659.HK) rose more than 6% in early trading. The NDA for self-developed injection KJ103 was accepted by NMPA.

According to the Securities Times APP, Boji Pharmaceutical-B (02659.HK) surged over 6% in early trading, as of press time, up 5.94% to 23.9 Hong Kong dollars, with a turnover of 1000.12 million Hong Kong dollars.